Evidence map›Paper›PMID 37305396›Full record

ArticleOncology research2021

LncRNA WEE2-AS1 knockdown inhibits the proliferation, migration and invasion of glioma cells via regulating miR-29b-2-5p/TPM3 axis.

Zhen Jia, Zhengting Qian, Yong Tang, Xiang Li, Yan Shi, Heng Xin, Youwu Fan, Heming Wu

Open access · hybridAbstract read
In one paragraph

Article in Oncology research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Molecular cloning ofAnimal biotechnology · 2024
    Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Zhen JiaNanjing Medical University, Nanjing, 210000, China.
Zhengting QianNanjing Medical University, Nanjing, 210000, China.
Yong TangDepartment of Neurosurgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China.
Xiang LiDepartment of Neurosurgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China.
Yan ShiDepartment of Neurosurgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China.
Heng XinNanjing Medical University, Nanjing, 210000, China.
Youwu FanNanjing Medical University, Nanjing, 210000, China.
Heming WuDepartment of Neurosurgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China.
Nanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glioma is a general malignant tumor with a dismal prognosis. Long noncoding RNAs (lncRNAs) have been implicated in the initiation and processes of tumors. An investigation of the GEPIA database revealed that long noncoding RNA WEE2 antisense RNA 1 (WEE2-AS1) is upregulated in glioma tissues compared to normal brain tissues, and validation with quantitative real-time polymerase chain reaction (qRT-PCR) revealed that WEE2-AS1 expression was consistent with the database prediction. Fluorescence

Indexed as

GliomaMicroRNAsRNA, Long NoncodingCell ProliferationHumansIn Situ Hybridization, FluorescenceTropomyosinMicroRNAsRNA, Long NoncodingTPM3 protein, humanTropomyosinGliomaLncRNA WEE2-AS1miR-29b-25pProliferationTPM3

Identifiers

PMID37305396
PMCPMC10207975
OpenAlexW4285823308

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.